Hydrocortisone for the treatment of refractory hypotension: a randomised controlled trial

Salas, G.; Travaglianti, M.; Leone, A.; Couceiro, C.; Rodríguez, S.; Fariña, D.

doi:10.1016/j.anpede.2014.06.001

Article information

Abstract

Introduction

Systemic hypotension is a common sign in critically sick infants. Several studies have suggested that the use of short series of corticosteroids increases arterial blood pressure and reduces the inotropic support needs in preterm neonates with hypotension. There are a small number of reports on the use of hydrocortisone (HC) for the treatment of refractory hypotension in infants.

Material and methods

To assess the effectiveness of hydrocortisone in the reduction of inotropic support in infants with refractory hypotension. Population: infants who required dopamine ≥ 14μg/kg/min and/or epinephrine.

Design

prospective, controlled, randomised, double-blind trial with placebo.

Intervention

HC: 2.5mg/kg every 12hours, for 48hours intravenously (intervention group [IG]); placebo: isotonic saline 1.25ml/kg/doses intravenously (placebo group [PG]) every 12hours, for 48hours. Randomisation was performed in blocks with blind assignment.

Results

A total of 50 infants with refractory systemic hypotension were prospectively recruited. Patient characteristics were similar in both groups. Requirements for inotropic support at 48hrs were achieved in 60% of the IG versus 24% of the PG (P=.009, RR: 2.5, 95% CI, 1.16-5.38). A significant association was observed between the administration of HC in infants treated with epinephrine and the presence of hyperglycaemia (P =.008).

Conclusion

In patients with refractory hypotension hydrocortisone administration reduced the need for inotropic support. Further studies with a greater number of patients are needed to confirm the effectiveness of HC as a therapeutic tool in these infants.

Keywords:

Hydrocortisone

Hypotension

Inotropes

Dopamine

Epinephrine

Steroids

Resumen

Introducción

La hipotensión arterial es un signo frecuente en recién nacidos críticamente enfermos. Varios estudios clínicos señalan que series cortas de corticoides aumentan la PA y disminuyen el requerimiento de inotrópicos en prematuros con hipotensión. Existe escaso número de estudios de empleo de hidrocortisona para el tratamiento de la hipotensión refractaria en recién nacidos (RNT). El objetivo de este estudio es evaluar la eficacia de la hidrocortisona (HC) para la reducción del soporte inotrópico en RNT con hipotensión arterial refractaria.

Material y métodos

Se incluyó a todos los RNT con requerimientos de dopamina ≥ 14μg/k/ min y/o epinefrina.

Diseño

prospectivo, controlado, aleatorizado, doble ciego con placebo.

Intervención

HC: 2,5mg/kg c/12h, por 48h por vía intravenosa (IV) (grupo intervención [GI]); placebo: solución fisiológica 1,25ml/kg/dosis IV (grupo placebo [GP]). Se efectuó aleatorización en bloques con asignación oculta.

Resultados

Ingresaron al estudio 50 RNT con hipotensión refractaria. No se observaron diferencias significativas entre los 2 grupos. La reducción del soporte inotrópico a las 48h en el GI se alcanzó en el 60% de los pacientes vs. el 24% en el GP (p = 0,009, RR = 2,5, IC del 95%, 1,16 a 5,38). Se observó una asociación significativa entre la administración de HC en RNT tratados con epinefrina y la presencia de hiperglucemia (p = 0,008).

Conclusión

La administración de HC en pacientes con hipotensión refractaria redujo la necesidad de soporte inotrópico. Estos datos contribuyen a continuar investigando acerca del papel de los esteroides en el soporte hemodinámico de pacientes críticos.

Palabras clave:

Hidrocortisona

Hipotensión

Inotrópicos

Dopamina

Epinefrina

Esteroides

Full text is only aviable in PDF

References

[1]

S. Noori, I. Seri.

Pathophysiology of newborn hypotension outside the transitional period.

Early Human Development., 81 (2005), pp. 399-404

http://dx.doi.org/10.1016/j.earlhumdev.2005.03.007 | Medline

[2]

A. Pellicer, M.C. Bravo, R. Madero, S. Salas, J. Quero, F. Cabañas.

Early systemic hypotension and vasopressor support in low birth weight infants: Impact on neurodevelopment.

Pediatrics., 123 (2009), pp. 1369-1376

http://dx.doi.org/10.1542/peds.2008-0673 | Medline

[3]

S. Noori, I. Seri.

Neonatal blood pressure support: The use of inotropes, lusitropes, and other vasopressor agents.

Clin Perinatol., 39 (2012), pp. 221-238

http://dx.doi.org/10.1016/j.clp.2011.12.010 | Medline

[4]

S.G. Golombek, D. Fariña, A. Sola, H. Baquero, F. Cabañas, F. Dominguez, et al.

Segundo consenso clínico de la Sociedad Iberoamericana de Neonatología: manejo hemodinámico del recién nacido.

Rev Panam Salud Publica., 29 (2011), pp. 281-302

Medline

[5]

E.F. Fernandez, K. Watterberg.

Relative adrenal insufficiency in the preterm and term infant.

J Perinatol., 29 (2009), pp. S44-S49

http://dx.doi.org/10.1038/jp.2009.24 | Medline

[6]

W.P. Hausdorff, M.G. Caron, R.J. Lefkowitz.

Turning off the signal: Desensitization of β-adrenergic receptor function.

FASEB J., 4 (1990), pp. 2881-2889

Medline

[7]

M. Wehling.

Specific, nongenomic actions of steroid hormones.

Annu Rev Physiol., 59 (1997), pp. 365-393

http://dx.doi.org/10.1146/annurev.physiol.59.1.365 | Medline

[8]

P.E. Bollaert, C. Charpentier, B. Levy, M. Debouverie, G. Audibert, A. Larcan.

Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

Crit Care Med., 26 (1998), pp. 645-650

Medline

[9]

M. Hatherill, S. Tibby, T. Hilliard, C. Turner, I. Murdoch.

Adrenal insufficiency in septic shock.

Arch Dis Child., 80 (1999), pp. 51-55

Medline

[10]

J. Brierley, J. Carcillo, K. Choong, T. Cornell, A. DeCaen, A. Deymann, et al.

Task Force Committee Members Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. 2007 update from the American College of Critical Care Medicine.

Crit Care Med., 37 (2009), pp. 666-681

http://dx.doi.org/10.1097/CCM.0b013e31819323c6 | Medline

[11]

I. Seri, J. Evans.

Controversies in the diagnosis and management of hypotension in the newborn infant.

Curr Opin Pediatr., 13 (2001), pp. 116-123

Medline

[12]

I. Seri, R. Tan, J. Evans.

Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension.

Pediatrics., 107 (2001), pp. 1070-1074

Medline

[13]

P.C. Ng, C.W.K. Lam, T.F. Fok, C.H. Lee, K.C. Ma, I.H.S. Chan, et al.

Refractory hypotension in preterm infants with adrenocortical insufficiency.

Arch Dis Child Fetal Neonatal Ed., 84 (2001), pp. F122-F124

Medline

[14]

I. Seri, J. Evans.

Why do steroids increase blood pressure in preterm infants?.

J Pediatr., 136 (2000), pp. 420-421

Medline

[15]

K. Watterberg.

Evidence-based neonatal pharmacotherapy: Postnatal corticosteroids.

Clin Perinatol., 39 (2012), pp. 47-59

http://dx.doi.org/10.1016/j.clp.2011.12.017 | Medline

[16]

A.B. Zubrow, S. Hulman, H. Kushner, B. Falkner.

Determinants of blood pressure in infants admitted to neonatal intensive care units: A prospective multicenter study.

J Perinatol., 15 (1995), pp. 470-479

Medline

[17]

D. Moher, S. Hopewell, K.F. Schulz, V. Montori, P.C. Gøtzsche, P.J. Devereaux, et al.

for the CONSORT Group CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

J Clin Epi., 63 (2010), pp. e1-e37

[18]

S. Higgins, P. Friedlich, I. Seri.

Hydrocortisone for hypotension and vasopressor dependence in preterm neonates: A meta-analysis.

J Perinatol., 30 (2010), pp. 373-378

http://dx.doi.org/10.1038/jp.2009.126 | Medline

[19]

P. Ng, C.H. Lee, F.L. Bnura, I.H.S. Chan, A.W.Y. Lee, E. Wong, et al.

A double-blind, randomized, controlled study of a «stress dose» of hydrocortisone for rescue treatment of refractory hypotension in preterm infants.

Pediatrics., 117 (2006), pp. 367-375

http://dx.doi.org/10.1542/peds.2005-0869 | Medline

[20]

M. Efird, A. Heerens, P. Gordon, C.L. Bose, D.A. Young.

A randomized- controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants.

J Perinatol., 25 (2005), pp. 119-124

http://dx.doi.org/10.1038/sj.jp.7211193 | Medline

[21]

R.E. Gaissmaier, F. Pohlandt.

Single-dose dexamethasone treatment of hypotension in preterm infants.

J Pediatr., 134 (1999), pp. 701-705

Medline

[22]

Ibrahim H, Sinha IP, Subhedar NV. Corticosteroids for treating hypotension in preterm infants. Cochrane Database of Systematic Reviews. 2011;Issue 12.

[23]

K.J. Millar, R.R. Thiagarajan, P.C. Laussen.

Glucocorticoid therapy for hypotension in the cardiac intensive care unit.

Pediatr Cardiol., 28 (2007), pp. 176-182

http://dx.doi.org/10.1007/s00246-006-0053-9 | Medline

[24]

C.H. Casartelli, P.C. Garcia, R.G. Branco, J.P. Piva, P.R. Einloft, R.C. Tasker.

Adrenal response in children with septic shock.

Intensive Care Med., 33 (2007), pp. 1609-1613

http://dx.doi.org/10.1007/s00134-007-0699-7 | Medline

[25]

C.F. Pizarro, E.J. Troster, D. Damiani, J. Carcillo.

Absolute and relative adrenal insufficiency in children with septic shock.

Crit Care Med., 33 (2005), pp. 855-859

Medline

[26]

C.F.W. Baker, J.D.E. Barks, C. Engmann, D.M. Vazquez, C.R. Neal, R.E. Schumacher.

Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns.

J Perinatol., 28 (2008), pp. 412-419

http://dx.doi.org/10.1038/jp.2008.16 | Medline

[27]

P. Tantivit, N. Subramanian, M. Garg, R. Ramanathan, R.A. deLemos.

Low serum cortisol in term newborns with refractory hypotension.

J Perinatol., 19 (1999), pp. 432-437

Medline

[28]

S. Noori, P. Friedlich, P. Wong, M. Ebrahimi, B. Siassi, I. Seri.

Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates.

Pediatrics., 118 (2006), pp. 1456-1466

http://dx.doi.org/10.1542/peds.2006-0661 | Medline

[29]

B.D. Kamath, L. Fashaw, J.P. Kinsella.

Adrenal insufficiency in newborns with congenital diaphragmatic hernia.

J Pediatr., 156 (2010), pp. 495-497

http://dx.doi.org/10.1016/j.jpeds.2009.10.044 | Medline

[30]

G. Goldsmit, C. Rabasa, S. Rodríguez, Y. Aguirre, M. Valdés, D. Pretz, et al.

Factores de riesgo asociados a deterioro clínico en el traslado de recién nacidos enfermos.

Arch Argent Pediatr., 110 (2012), pp. 304-310

http://dx.doi.org/10.5546/aap.2012.304 | Medline

☆

Presented at the 46th meeting of the Sociedad Latinoamericana de Investigación Pediátrica [Latin American Association for Paediatric Research] 2008. Sociedad Iberoamericana de Neonatología [Ibero-American Society of Neonatology]. Cusco, Peru, September 2008.

☆☆

Please cite this article as: Salas G, Travaglianti M, Leone A, Couceiro C, Rodríguez S, Fariña D. Hidrocortisona para el tratamiento de hipotensión refractaria: ensayo clínico controlado y aleatorizado. An Pediatr (Barc). 2014;80(6):387-393.

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter